Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2025)

Historic Inventory Average for BioNexus Gene Lab (BGLC) over the last 7 years, with Q3 2025 value amounting to $1.1 million.

  • BioNexus Gene Lab's Inventory Average fell 821.64% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 821.64%. This contributed to the annual value of $1.3 million for FY2024, which is 1941.87% up from last year.
  • As of Q3 2025, BioNexus Gene Lab's Inventory Average stood at $1.1 million, which was down 821.64% from $1.2 million recorded in Q2 2025.
  • BioNexus Gene Lab's Inventory Average's 5-year high stood at $1.6 million during Q3 2021, with a 5-year trough of $938721.5 in Q1 2023.
  • Moreover, its 5-year median value for Inventory Average was $1.2 million (2024), whereas its average is $1.3 million.
  • Per our database at Business Quant, BioNexus Gene Lab's Inventory Average soared by 1778494.35% in 2021 and then crashed by 4078.99% in 2023.
  • Over the past 5 years, BioNexus Gene Lab's Inventory Average (Quarter) stood at $1.5 million in 2021, then plummeted by 31.1% to $1.0 million in 2022, then grew by 8.29% to $1.1 million in 2023, then grew by 23.69% to $1.4 million in 2024, then dropped by 19.97% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.